View in EDS HTML Full Text PDF Full Text

Targeting RAD51-Mediated Homologous Recombination as a Treatment for Advanced Solid and Hematologic Malignancies: Opportunities and Challenges Ahead.

Saved in:
Bibliographic Details
Title: Targeting RAD51-Mediated Homologous Recombination as a Treatment for Advanced Solid and Hematologic Malignancies: Opportunities and Challenges Ahead.
Authors: Tsang ES; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA, 94158, USA., Munster PN; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA, 94158, USA.
Source: OncoTargets and therapy [Onco Targets Ther] 2022 Dec 13; Vol. 15, pp. 1509-1518. Date of Electronic Publication: 2022 Dec 13 (Print Publication: 2022).
Publication Type: Journal Article; Review
Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101514322 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6930 (Print) Linking ISSN: 11786930 NLM ISO Abbreviation: Onco Targets Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36536949
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting RAD51-Mediated Homologous Recombination as a Treatment for Advanced Solid and Hematologic Malignancies: Opportunities and Challenges Ahead.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tsang+ES%22">Tsang ES</searchLink>; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA, 94158, USA.<br /><searchLink fieldCode="AU" term="%22Munster+PN%22">Munster PN</searchLink>; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA, 94158, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101514322%22">OncoTargets and therapy</searchLink> [Onco Targets Ther] 2022 Dec 13; Vol. 15, pp. 1509-1518. <i>Date of Electronic Publication: </i>2022 Dec 13 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Medical+Press%22">Dove Medical Press </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101514322 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1178-6930 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211786930%22">11786930 </searchLink><i>NLM ISO Abbreviation: </i>Onco Targets Ther <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36536949
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/OTT.S322297
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1509
    Titles:
      – TitleFull: Targeting RAD51-Mediated Homologous Recombination as a Treatment for Advanced Solid and Hematologic Malignancies: Opportunities and Challenges Ahead.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tsang ES
      – PersonEntity:
          Name:
            NameFull: Munster PN
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 12
              Text: 2022 Dec 13
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 1178-6930
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: OncoTargets and therapy
              Type: main
ResultId 1